Dietz HC, Pyeritz RE. Mutations in the human gene for fibrillin- 1 (FBN1) in the Marfan syndrome and related disorders. Human Molecular Genetics 4: 1799-11809; 1995
Sumera N. Hasham et al. Genetic Basis Of Thoracic Aortic Aneurysms And Dissections. Opin Cardiol 2002, 17:677-683
John CS Dean. Management of Marfan Syndrome. Heart 88:97-103; 2002
Beighton P, De Paepe A, Danks D, et al. International Nosology of Heritable Disorders of Connective Tissue. Am J Med Genet 29:581-94; 1988
Tom Treasure. Cardiovascular Surgery for Marfan Syndrome. Heart 84:674-678; 2000
Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term -adrenergic blockade in Marfan's Syndrome. N Engl J Med 330:1335-41; 1994
Groenink M, Lohuis TAJ, Tijssen, et al. Survival And Complication Free Survival In Marfan's Syndrome: Implications Of Current Guidelines. Heart 82: 499-450; 1999
Haouzi A, Berglund H, Pelikan PCD, et al. Heterogenous aortic response to acute beta-adrenergic blockade in Marfan's Syndrome. Am Heart J 133:60-3; 1997
Groenink M, de Roos A, Mulder BJM, et al. Changes In Aortic Distensibility And Pulse Wave Velocity Assessed With Magnetic Resonance Imaging Following Beta-Blockade Therapy In The Marfan Syndrome. Am J Cardiol 82:203-8; 1998
Rios AS, Silber EN, Bavishi N, et al. Effects of long-term beta- adrenergic blockade on aortic root complicance in patients with Marfan Syndrome. Am Heart J 137:1057-61; 1999
Nagashima H et al. Angiotensin II Type 2 Receptor Mediates Muscle Cell Apoptosis In Cystic Medial Degeneration Associated With Marfan's Syndrome. Circulation 104(suppl I):I-282-7; 2001
Treasure T et al. The Timing Of Aortic Root Replacement In The Marfan Syndrome: Computerised Decision Support. In: Enker J, Ed. Cardiac Surgery And Concomitant Disease. Berlin: Springer; 1999.
Hal Dietz, M.D. Current Research. National Marfan Foundation Journal. Vol 17
